Search research articles
Contact Us
Filters
Showing results (81-90 of 98) with videos related to
Page
of 10
Sort By:
Clinical Pharmacology and Therapeutics
|
March 1, 1994
Variable disposition kinetics and electrocardiographic effects of flecainide during repeated dosing in humans: contribution of genetic factors, dose-dependent clearance, and interaction with amiodarone
C Funck-Brentano, L Becquemont, H K Kroemer, et al.
Clinical Pharmacology and Therapeutics
|
May 9, 2000
Combined glutathione-S-transferase M1 and T1 genetic polymorphism and tacrine hepatotoxicity
T Simon, L Becquemont, M Mary-Krause, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 23, 2015
Plasma vemurafenib concentrations in advanced BRAFV600mut melanoma patients: impact on tumour response and tolerance
E Funck-Brentano, J C Alvarez, C Longvert, et al.
Journal of Cardiovascular Pharmacology
|
September 1, 1989
Pharmacokinetic and pharmacodynamic interaction of N-acetyl procainamide and procainamide in humans
C Funck-Brentano, R T Light, M D Lineberry, et al.
British Journal of Clinical Pharmacology
|
December 12, 2001
Variability of cytochrome P450 1A2 activity over time in young and elderly healthy volunteers
T Simon, L Becquemont, B Hamon, et al.
Rheumatology (Oxford, England)
|
January 5, 2007
Heart conduction disorders related to antimalarials toxicity: an analysis of electrocardiograms in 85 patients treated with hydroxychloroquine for connective tissue diseases
N Costedoat-Chalumeau, J-S Hulot, Z Amoura, et al.
Clinical Pharmacology and Therapeutics
|
May 1, 1991
Genetically determined stereoselective excretion of encainide in humans and electrophysiologic effects of its enantiomers in canine cardiac Purkinje fibers
J Turgeon, C Funck-Brentano, H T Gray, et al.
European Journal of Clinical Pharmacology
|
April 11, 2001
Is diclofenac a valuable CYP2C9 probe in humans?
S Morin, M A Loriot, J M Poirier, et al.
European Journal of Clinical Pharmacology
|
March 14, 2003
Genetic and environmental risk factors for oral anticoagulant overdose
C Verstuyft, A Robert, S Morin, et al.
Circulation
|
May 1, 1989
Stereoselective disposition and pharmacologic activity of propafenone enantiomers
H K Kroemer, C Funck-Brentano, D J Silberstein, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 98) with videos related to
Sort By:
Page
of 10
Clinical Pharmacology and Therapeutics
|
March 1, 1994
Variable disposition kinetics and electrocardiographic effects of flecainide during repeated dosing in humans: contribution of genetic factors, dose-dependent clearance, and interaction with amiodarone
C Funck-Brentano, L Becquemont, H K Kroemer, et al.
Clinical Pharmacology and Therapeutics
|
May 9, 2000
Combined glutathione-S-transferase M1 and T1 genetic polymorphism and tacrine hepatotoxicity
T Simon, L Becquemont, M Mary-Krause, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 23, 2015
Plasma vemurafenib concentrations in advanced BRAFV600mut melanoma patients: impact on tumour response and tolerance
E Funck-Brentano, J C Alvarez, C Longvert, et al.
Journal of Cardiovascular Pharmacology
|
September 1, 1989
Pharmacokinetic and pharmacodynamic interaction of N-acetyl procainamide and procainamide in humans
C Funck-Brentano, R T Light, M D Lineberry, et al.
British Journal of Clinical Pharmacology
|
December 12, 2001
Variability of cytochrome P450 1A2 activity over time in young and elderly healthy volunteers
T Simon, L Becquemont, B Hamon, et al.
Rheumatology (Oxford, England)
|
January 5, 2007
Heart conduction disorders related to antimalarials toxicity: an analysis of electrocardiograms in 85 patients treated with hydroxychloroquine for connective tissue diseases
N Costedoat-Chalumeau, J-S Hulot, Z Amoura, et al.
Clinical Pharmacology and Therapeutics
|
May 1, 1991
Genetically determined stereoselective excretion of encainide in humans and electrophysiologic effects of its enantiomers in canine cardiac Purkinje fibers
J Turgeon, C Funck-Brentano, H T Gray, et al.
European Journal of Clinical Pharmacology
|
April 11, 2001
Is diclofenac a valuable CYP2C9 probe in humans?
S Morin, M A Loriot, J M Poirier, et al.
European Journal of Clinical Pharmacology
|
March 14, 2003
Genetic and environmental risk factors for oral anticoagulant overdose
C Verstuyft, A Robert, S Morin, et al.
Circulation
|
May 1, 1989
Stereoselective disposition and pharmacologic activity of propafenone enantiomers
H K Kroemer, C Funck-Brentano, D J Silberstein, et al.
Page
of 10